A Randomized Controlled Trial (RCT) Comparing Clostridium Histolyticum With Needle Aponeurotomy.
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 08 Dec 2016
Price : $35 *
At a glance
- Drugs Collagenase clostridium histolyticum (Primary)
- Indications Dupuytren's contracture
- Focus Therapeutic Use
- 04 Dec 2016 Planned End Date changed from 1 Jun 2021 to 1 Nov 2021.
- 04 Dec 2016 Planned primary completion date changed from 1 Nov 2016 to 1 Nov 2021.
- 04 Dec 2016 Status changed from recruiting to active, no longer recruiting.